May 15, 2026 5:00 pm EDT TuHURA Biosciences Reports First Quarter 2026 Financial Results and Provides a Corporate Update
May 12, 2026 7:30 am EDT TuHURA Biosciences to Present at the 4th Annual H.C. Wainwright BioConnect Investor Conference
Apr 22, 2026 7:30 am EDT TuHURA Biosciences Announces $50 Million Credit Facility and Royalty Transaction Extending Anticipated Cash Runway into 2028
Apr 7, 2026 7:45 am EDT TuHURA Biosciences Appoints Amanda Garofalo, MSHS, as Senior Vice President of Clinical Operations
Apr 1, 2026 7:45 am EDT TuHURA Biosciences Reports Fourth Quarter and Full Year 2025 Financial Results and Provides a Corporate Update
Mar 23, 2026 7:45 am EDT Craig Tendler, M.D., JNJ's Former Global Head of Oncology Clinical Development, to Lead TuHURA Bioscience's VISTA Program in AML and other Blood Related Cancers
Feb 27, 2026 7:30 am EST TuHURA Biosciences Regains Compliance with Nasdaq Minimum Bid Price Requirement
Feb 17, 2026 7:45 am EST TuHURA Files Investigational New Drug Application for TBS-2025 in the Treatment of Blood-Related Cancers
Feb 12, 2026 7:45 am EST TuHURA Biosciences to Present at the Oppenheimer 36th Annual Healthcare Life Sciences Conference